RxDoctor Payments DataLook up a doctor →

Ross Guarino

Surgical · Williamsville, NYNPI 1487703898

Payments from drug & device makers

$12,910in general payments, 2019–2025

Across 652 payments — averaging $19.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$3K
  • Collegium Pharmaceutical, Inc.$1K
  • Boston Scientific$1K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$839
  • Vanda Pharmaceuticals Inc.$737
  • Amgen$578
  • plus $6K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott106$2,728
Collegium Pharmaceutical, Inc.117$1,181
Boston Scientific40$1,153
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC88$839
Vanda Pharmaceuticals Inc.41$737
Amgen(2 entities)31$578
Nevro Corp.15$560
AbbVie17$540
Curonix LLC3$494
Biohaven Pharmaceuticals, Inc.36$349
SPR Therapeutics, Inc5$338
Protega Pharmaceutials Inc5$305
Biohaven Pharmaceutical Holding Company Ltd.40$279
Pfizer8$216
Biogen2$197
Medtronic3$167
Scilex Pharmaceuticals Inc.9$158
Pacira Therapeutics, Inc.2$144
GRT US Holding, Inc.3$122
SK Life Science, Inc.1$113
Impel Pharmaceuticals Inc.1$105
Livanova USA, Inc.1$92
Averitas Pharma Inc.4$89
Lilly USA, LLC4$76
Si-bone, Inc.4$72
Kyowa Kirin, Inc.3$70
Saluda Medical Americas, Inc.1$67
Amneal Pharmaceuticals LLC4$63
Teva Pharmaceuticals USA, Inc.4$62
Johnson & Johnson(2 entities)3$61
UCB, Inc.2$58
Virtus Pharmaceuticals LLC4$53
Lundbeck LLC3$51
Almatica Pharma LLC3$50
Novartis2$48
Takeda Pharmaceuticals U.S.A., Inc.2$47
Redhill Biopharma Inc.2$46
Upsher-smith Laboratories LLC2$43
Eisai Inc.2$41
Mallinckrodt Hospital Products Inc.1$40
Catalyst Pharmaceuticals, Inc.2$38
Acorda Therapeutics, Inc2$38
Tonix Medicines, Inc.1$33
Alkermes, Inc.2$33
IBSA Pharma Inc.2$33
Azurity Pharmaceuticals, Inc.2$30
MDD US Operations, LLC2$30
Supernus Pharmaceuticals, Inc.2$28
Argenx US, Inc.1$24
Indivior Inc.1$24
Foundation Fusion Solutions, LLC2$24
EMD Serono, Inc.1$23
GSK1$22
Vertex1$21
Ferring Pharmaceuticals Inc.1$18
Bristol Myers Squibb1$14
Kowa Pharmaceuticals America, Inc.1$14
Biodelivery Sciences International, Inc.1$13
Banner Life Sciences, LLC1$12
Arbor Pharmaceuticals, Inc.1$12

How this compares

$12,910 in reported general payments places this provider in the 95th percentile of 1,544 surgical providers in New York.

See all surgical providers in New York →

Medicare billing

Part B allowed, 2024
$34,465
Medicare patients
108
Services billed
411

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other surgical in Williamsville

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →